Step-by-step: deflect eligibility pre screening chatbot q…

Start by mapping the current eligibility query load. Track how many emails, calls, and form submissions your coordinators handle each week for a single active trial. Look for the repeat questions: “Do I qualify if I have X condition?” or “What stage of treatment applies?” Identify the three-to-five protocols generating the most volume – these are your first agents.

Assess what information patients must provide before a coordinator can make a decision. Typical data points include age, diagnosis, prior therapies, and current medications. This shapes your custom action forms, not a natural-language back-and-forth that can drift off-script.

Decide which source documents to feed the knowledge base. Use the full protocol document, the patient-facing informed consent form, and the recruitment brochure. Avoid training on third-party articles or general medical content – your agent must answer only from your study’s specific criteria.

Finally, agree on disqualification language. When a patient clearly does not meet a hard exclusion (e.g., outside age range), the agent should explain why without providing medical advice or encouraging protocol waivers. Draft these response snippets now so they can be loaded during setup.

Create a new agent in your Chatref workspace for a single trial. Upload the study protocol, inclusion/exclusion tables, and recruitment materials to the knowledge base. Chatref learns these documents so answers come from your study, not generic medical summaries. For a multi-site study, ensure all sites provide the same core documents to keep responses consistent across locations.

Configure the agent’s custom actions. Build a form flow that collects patient demographics, diagnosis history, and current treatments. Map each field to a specific eligibility criterion – for example, a “last chemotherapy date” field directly checks the protocol’s washout period. Set the agent to trigger a CRM or EDC notification when a candidate meets initial screens, using the integration your site already has in place.

Test with real scenarios before anyone external sees the agent. Have coordinators submit batches of known eligible and ineligible profiles. Verify the agent correctly identifies hard exclusions, asks follow-up questions where criteria are conditional, and hands off smoothly when a case is borderline. Adjust the threshold for human handoff – you do not want the agent making final eligibility determinations, only filtering clear ins and outs.

Pilot the agent on a single trial’s recruitment page for one week with a limited audience. Post a notice that an instant pre-screening assistant is available, and monitor the conversation inbox alongside your coordinators. During this window, keep the handoff threshold low – allow coordinators to intercept any case the agent flags as uncertain, then gradually tighten the filter as performance stabilizes.

Train coordinators on what changes. Explain they will now review a daily digest of pre-screened candidates instead of raw inquiries. Show them how to access the conversation inbox, read the custom action data, and pick up a chat when the agent escalates. Emphasize that their role shifts to decision-making on vetted profiles, not data collection.

Expand to additional trials after the pilot shows a reliable deflection rate. Each new agent follows the same setup sequence: upload trial-specific documents, configure custom actions mirroring that protocol’s criteria, and test with coordinator-approved profiles. Avoid copying one agent across trials with different eligibility rules – a one-size agent produces inaccurate screens that coordinators will learn to ignore.

Track the number of pre-screening conversations the agent handles versus the number that reach a coordinator. A successful deflection means a patient answered all eligibility questions through custom actions and received a clear outcome (note: we proceed or you do not qualify for this reason) without human intervention. Aim for steady improvement over two-to-four weeks, not an immediate target.

Measure coordinator time recovered. Ask teams to note how many hours per week they previously spent on pre-screening calls and emails. Compare to the time they now spend reviewing agent summaries and handoffs. Even a partial deflection – where the agent collects all the data but a coordinator still decides – reduces data-gathering work substantially.

Review agent performance monthly against protocol amendments. When a trial adds a new exclusion or adjusts a dose escalation rule, update the source documents in the knowledge base immediately. A stale agent screens against old criteria and erodes trust. Set a recurring calendar task aligned with your IRB submission timelines so knowledge base updates happen as part of the amendment workflow, not as an afterthought.

What causes eligibility pre screening chatbot problems for Clinical Trial Sites & CROs?

The most common failure is training the agent on generic medical information instead of the specific trial protocol and informed consent documents. This produces answers that miss or misread exclusion criteria, forcing coordinators to re-screen every candidate. Other problems include failure to collect key data points through custom actions (leaving gaps the coordinator must fill), unclear handoff rules for borderline cases, and stale knowledge when a protocol amendment changes criteria without a corresponding update to the agent’s source content.

How do I improve eligibility pre screening chatbot for Clinical Trial Sites & CROs?

Ground the agent exclusively in your trial documents – upload the full protocol, consent forms, and recruitment materials to the knowledge base, not general references – and set up custom actions that map directly to each inclusion and exclusion criterion so patients provide structured data rather than free-text narratives. Test with batches of known eligible and ineligible profiles before launch, and schedule knowledge base updates to coincide with every protocol amendment. After deployment, review handoff conversations weekly to spot criteria the agent flags incorrectly and adjust its response boundaries. For broader guidance on setting up agents across trial sites, see our resource on Clinical Trial Sites & CROs.